Fidelity Investments’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $94.6K | Buy |
|
|||||
|
2025
Q2 | $58.1K | Sell |
|
|||||
|
2025
Q1 | $276K | Sell |
|
|||||
|
2024
Q4 | $869K | Buy |
|
|||||
|
2024
Q3 | $776K | Buy |
|
|||||
|
2024
Q2 | $370K | Sell |
|
|||||
|
2024
Q1 | $1.01M | Buy |
|
|||||
|
2023
Q4 | $287K | Buy |
|
|||||
|
2023
Q3 | $28.1K | Sell |
|
|||||
|
2023
Q2 | $3.34M | Buy |
|
|||||
|
2023
Q1 | $2.59M | Buy |
|
|||||
|
2022
Q4 | $34.7K | Sell |
|
|||||
|
2022
Q3 | $605K | Sell |
|
|||||
|
2022
Q2 | $1.13M | Sell |
|
|||||
|
2022
Q1 | $23.3M | Sell |
|
|||||
|
2021
Q4 | $38.7M | Buy |
|
|||||
|
2021
Q3 | $48.1M | Sell |
|
|||||
|
2021
Q2 | $69.7M | Buy |
|
|||||
|
2021
Q1 | $30.8M | Sell |
|
|||||
|
2020
Q4 | $105M | Sell |
|
|||||
|
2020
Q3 | $99.2M | Sell |
|
|||||
|
2020
Q2 | $89.7M | Sell |
|
|||||
|
2020
Q1 | $100M | Buy |
|
|||||
|
2019
Q4 | $80.7M | Sell |
|
|||||
|
2019
Q3 | $54.7M | Buy |
|
|||||
|
2019
Q2 | $67.3M | Buy |
|
|||||
|
2019
Q1 | $9.38M | Sell |
|
|||||
|
2018
Q4 | $10.1M | Sell |
|
|||||
|
2018
Q3 | $17.1M | Sell |
|
|||||
|
2018
Q2 | $24.2M | Hold |
|
|||||
|
2018
Q1 | $32M | Buy |
|
|||||
|
2017
Q4 | $14.4M | Hold |
|
|||||
|
2017
Q3 | $13.9M | Sell |
|
|||||
|
2017
Q2 | $20.8M | Sell |
|
|||||
|
2017
Q1 | $28.6M | Sell |
|
|||||
|
2016
Q4 | $31.1M | Sell |
|
|||||
|
2016
Q3 | $45.7M | Sell |
|
|||||
|
2016
Q2 | $45.7M | Buy |
|
|||||
|
2016
Q1 | $28.2M | Sell |
|
|||||
|
2015
Q4 | $44.1M | Sell |
|
|||||
|
2015
Q3 | $33.4M | Hold |
|
|||||
|
2015
Q2 | $53.2M | Buy |
|
|||||
|
2015
Q1 | $69.6M | Buy |
|